Dynavax Technologies
DVAX
#4921
Rank
โ‚ฌ1.65 B
Marketcap
14,13ย โ‚ฌ
Share price
0.00%
Change (1 day)
16.33%
Change (1 year)

Market capitalization of Dynavax Technologies (DVAX)

Last known market cap: โ‚ฌ1.65 Billion

As of November 2026 Dynavax Technologies has a market cap of โ‚ฌ1.65 Billion. This makes Dynavax Technologies the world's 4921th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dynavax Technologies from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ1.65 B7.92%
2025โ‚ฌ1.53 B-6.38%
2024โ‚ฌ1.64 B0.46%
2023โ‚ฌ1.63 B29.17%
2022โ‚ฌ1.26 B-15.08%
2021โ‚ฌ1.49 B273.82%
2020โ‚ฌ0.39 B-6.91%
2019โ‚ฌ0.42 B-14.82%
2018โ‚ฌ0.50 B-46.76%
2017โ‚ฌ0.94 B552.75%
2016โ‚ฌ0.14 B-82.97%
2015โ‚ฌ0.84 B132.94%
2014โ‚ฌ0.36 B-2.22%
2013โ‚ฌ0.37 B-5.3%
2012โ‚ฌ0.39 B21.49%
2011โ‚ฌ0.32 B16.56%
2010โ‚ฌ0.27 B417%
2009โ‚ฌ53.79 M124.66%
2008โ‚ฌ23.94 M-82.79%
2007โ‚ฌ0.13 B-49.63%
2006โ‚ฌ0.27 B228.41%
2005โ‚ฌ84.13 M-39.74%
2004โ‚ฌ0.13 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚ฌ142.37 B 8,480.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ214.81 B 12,846.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ33.63 B 1,927.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ188.18 B 11,241.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ300.51 B 18,011.92%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ246.49 B 14,756.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ87.27 B 5,159.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
โ‚ฌ0.24 B-85.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ41.72 B 2,414.97%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel